William Greene, MD
Dr. Greene has served as CEO and a Director of Iconic Therapeutics since April 2014. Dr. Greene joined Iconic from MPM Capital, where he served as Managing Director and member of the Investment Committee leading investments and serving on Boards of emerging biopharmaceutical companies.
Previously, Dr. Greene was a Senior Clinical Scientist and Epidemiologist at Genentech, responsible for clinical strategy, trial design and execution, and regulatory interactions in several therapeutic areas at all development stages. While at Genentech, Dr. Greene led early clinical development of Lucentis®. Prior to Genentech, Dr. Greene was at Yale Medical School as a Resident in Internal Medicine and Diagnostic Radiology and a Fellow in Epidemiology. Dr. Greene received a B.A. from Wesleyan University and an M.D. from UCSF.